<DOC>
	<DOCNO>NCT01877057</DOCNO>
	<brief_summary>The increase prevalence overweight obesity among population contributes increase incidence chronic metabolic disease . Healthcare cost related disease rise ; prevention delay onset disorder associate overweight need . Food ingestion exerts transient suppressive effect appetite food intake release gastrointestinal hormone . Proteins show satiate carbohydrate fat . Intraduodenal administration ( via naso-duodenal intubation ) pea protein show reduce food intake increase satiety hormone level human , contrast orally dose ( unprotected ) pea protein . In present study aim investigate effect human gastric fluid degradability five different protect pea protein product . Further , ex vivo experiment freshly obtain human duodenum tissue apply Ussing chamber technology ; aim investigate intestinal satiety hormone release five different prototype . The prototype le degrade human gastric fluid effective intestinal satiety hormone release use future clinical trial .</brief_summary>
	<brief_title>Protected Pea Protein Extract Satiety Hormone Release</brief_title>
	<detailed_description />
	<mesh_term>Overweight</mesh_term>
	<mesh_term>Hormones</mesh_term>
	<criteria>Healthy men/women BMI 18 25 kg/m2 Consistently stable body weight least 6 month ( ± 2 kg ) Type 2 diabetes mellitus ( define fast plasma glucose ≥ 7.0 mmol/L ) ; Gastroenterological diseases abdominal surgery ( uncomplicated appendectomy , cholecystectomy hysterectomy allow , surgery upon judgment principle investigator ) ; Cardiovascular disease , cancer , liver kidney malfunction , autoimmune disease , disease life expectancy short 5 year ; Abuse product ; alcohol ( &gt; 20 alcoholic consumption per week ) drug Smoking Plans lose weight follow hypocaloric diet ; Use medication , include vitamin supplementation , except oral contraceptive , within 14 day prior test ; Regular use laxation product ; Use antibiotic 90 day prior start study . Administration investigational drug participation scientific intervention study may interfere study ( decided principle investigator ) , 90 day prior study Known pregnancy , lactation ( checked pregnancy test start study ) Blood donation within 3 month study period Selfadmitted HIVpositive state</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>Pea protein</keyword>
	<keyword>Satiety hormone</keyword>
	<keyword>Ussing Chamber</keyword>
</DOC>